Mitsubishi UFJ Trust & Banking’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.9M | Buy |
65,523
+14,768
| +29% | +$10.1M | 0.09% | 213 |
|
|
2026
Q1 | $39.2M | Buy |
50,755
+1,741
| +4% | +$1.33M | 0.1% | 207 |
|
|
2025
Q4 | $37.8M | Sell |
49,014
-13,806
| -22% | -$9.38M | 0.09% | 221 |
|
|
2025
Q3 | $35.3M | Sell |
62,820
-5,924
| -9% | -$3.35M | 0.08% | 261 |
|
|
2025
Q2 | $36.1M | Buy |
68,744
+204
| +0.3% | +$114K | 0.08% | 258 |
|
|
2025
Q1 | $43.5M | Sell |
68,540
-2,108
| -3% | -$1.45M | 0.11% | 199 |
|
|
2024
Q4 | $50.3M | Sell |
70,648
-5,676
| -7% | -$4.76M | 0.12% | 188 |
|
|
2024
Q3 | $80.2M | Sell |
76,324
-1,604
| -2% | -$1.79M | 0.18% | 118 |
|
|
2024
Q2 | $81.9M | Sell |
77,928
-7,865
| -9% | -$7.62M | 0.2% | 109 |
|
|
2024
Q1 | $82.6M | Sell |
85,793
-3,678
| -4% | -$3.5M | 0.19% | 121 |
|
|
2023
Q4 | $78.6M | Sell |
89,471
-973
| -1% | -$801K | 0.19% | 130 |
|
|
2023
Q3 | $74.4M | Sell |
90,444
-46,138
| -34% | -$36.3M | 0.19% | 122 |
|
|
2023
Q2 | $98.1M | Sell |
136,582
-241
| -0.2% | -$186K | 0.23% | 102 |
|
|
2023
Q1 | $112M | Sell |
136,823
-16,209
| -11% | -$12.2M | 0.27% | 89 |
|
|
2022
Q4 | $110M | Sell |
153,032
-25,220
| -14% | -$18.6M | 0.29% | 89 |
|
|
2022
Q3 | $123M | Sell |
178,252
-16,072
| -8% | -$10.1M | 0.34% | 68 |
|
|
2022
Q2 | $115M | Buy |
194,324
+8,699
| +5% | +$5.65M | 0.29% | 83 |
|
|
2022
Q1 | $130M | Sell |
185,625
-2,009
| -1% | -$1.27M | 0.3% | 82 |
|
|
2021
Q4 | $118M | Buy |
187,634
+16,040
| +9% | +$9.86M | 0.24% | 107 |
|
|
2021
Q3 | $104M | Buy |
171,594
+2,860
| +2% | +$1.78M | 0.22% | 112 |
|
|
2021
Q2 | $93.3M | Sell |
168,734
-5,207
| -3% | -$2.64M | 0.2% | 131 |
|
|
2021
Q1 | $82.9M | Buy |
173,941
+34,568
| +25% | +$16.8M | 0.18% | 134 |
|
|
2020
Q4 | $67.3M | Buy |
139,373
+12,959
| +10% | +$7M | 0.14% | 183 |
|
|
2020
Q3 | $70.8M | Buy |
126,414
+147
| +0.1% | +$89.1K | 0.16% | 152 |
|
|
2020
Q2 | $78.7M | Buy |
126,267
+47,492
| +60% | +$27M | 0.19% | 131 |
|
|
2020
Q1 | $38.5M | Buy |
78,775
+4,303
| +6% | +$1.77M | 0.11% | 210 |
|
|
2019
Q4 | $28M | Buy |
74,472
+170
| +0.2% | +$57.2K | 0.07% | 328 |
|
|
2019
Q3 | $20.3M | Buy |
74,302
+1,518
| +2% | +$449K | 0.05% | 373 |
|
|
2019
Q2 | $22.6M | Buy |
72,784
+4,468
| +7% | +$1.49M | 0.08% | 307 |
|
|
2019
Q1 | $27.7M | Buy |
68,316
+2,153
| +3% | +$887K | 0.1% | 239 |
|
|
2018
Q4 | $24.7M | Buy |
66,163
+2,807
| +4% | +$1.03M | 0.1% | 235 |
|
|
2018
Q3 | $25.6M | Sell |
63,356
-102,123
| -62% | -$38.9M | 0.09% | 262 |
|
|
2018
Q2 | $57.1M | Buy |
165,479
+2,503
| +2% | +$783K | 0.1% | 235 |
|
|
2018
Q1 | $56.1M | Buy |
162,976
+4,636
| +3% | +$1.61M | 0.1% | 231 |
|
|
2017
Q4 | $59.5M | Buy |
158,340
+136
| +0.1% | +$55.1K | 0.1% | 220 |
|
|
2017
Q3 | $70.7M | Sell |
158,204
-203
| -0.1% | -$96.6K | 0.13% | 184 |
|
|
2017
Q2 | $77.8M | Buy |
158,407
+1,730
| +1% | +$757K | 0.15% | 156 |
|
|
2017
Q1 | $60.7M | Buy |
156,677
+191
| +0.1% | +$70.8K | 0.12% | 200 |
|
|
2016
Q4 | $57.4M | Sell |
156,486
-2,082
| -1% | -$792K | 0.12% | 199 |
|
|
2016
Q3 | $63.7M | Buy |
158,568
+2,263
| +1% | +$908K | 0.13% | 187 |
|
|
2016
Q2 | $54.6M | Buy |
156,305
+2,691
| +2% | +$1.04M | 0.12% | 204 |
|
|
2016
Q1 | $55.4M | Buy |
153,614
+4,610
| +3% | +$1.9M | 0.12% | 193 |
|
|
2015
Q4 | $80.9M | Buy |
149,004
+801
| +0.5% | +$434K | 0.18% | 133 |
|
|
2015
Q3 | $68.9M | Buy |
148,203
+3,975
| +3% | +$2.13M | 0.17% | 141 |
|
|
2015
Q2 | $73.6M | Sell |
144,228
-6,618
| -4% | -$3.23M | 0.17% | 145 |
|
|
2015
Q1 | $68.1M | Buy |
150,846
+5,790
| +4% | +$2.45M | 0.16% | 159 |
|
|
2014
Q4 | $59.5M | Buy |
145,056
+2,524
| +2% | +$993K | 0.14% | 175 |
|
|
2014
Q3 | $51.4M | Sell |
142,532
-5,206
| -4% | -$1.74M | 0.13% | 191 |
|
|
2014
Q2 | $41.7M | Buy |
147,738
+1,181
| +0.8% | +$350K | 0.1% | 256 |
|
|
2014
Q1 | $44M | Buy |
146,557
+2,931
| +2% | +$903K | 0.11% | 234 |
|
|
2013
Q4 | $39.5M | Sell |
143,626
-1,652
| -1% | -$475K | 0.1% | 246 |
|
|
2013
Q3 | $45.5M | Buy |
145,278
+2,731
| +2% | +$718K | 0.12% | 199 |
|
|
2013
Q2 | $32.1M | Buy |
+142,547
| New | +$33.2M | 0.09% | 265 |
|
Other funds holding REGN
Mitsubishi UFJ Trust & Banking's REGN Position: Q2 2026 in Review
Mitsubishi UFJ Trust & Banking increased its Regeneron Pharmaceuticals (REGN) stake by 29% in Q2 2026, buying an estimated $10.1M and bringing the position to 65,523 shares worth $40.9M. The position accounts for 0.09% of the portfolio, ranked #213.
Mitsubishi UFJ Trust & Banking first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $130M in Q1 2022. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Mitsubishi UFJ Trust & Banking held 65,523 shares of Regeneron Pharmaceuticals worth $40.9M as of Q2 2026.
- Mitsubishi UFJ Trust & Banking bought 14,768 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.1M.
- Regeneron Pharmaceuticals made up 0.09% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #213 holding.
- Mitsubishi UFJ Trust & Banking first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Mitsubishi UFJ Trust & Banking's Regeneron Pharmaceuticals position peaked at $130M in Q1 2022.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.